RETATRUTIDE 10 mg

Retatrutide (10mg) – Triple GIP/GLP-1/Glucagon Receptor Agonist

Investigate multi-receptor metabolic pathways with Retatrutide, a novel triple-agonist peptide engineered for in-vitro and empirical research into targeted activity across GIP, GLP-1, and glucagon receptors. Supplied strictly as a research chemical, Retatrutide is evaluated for its comprehensive role in cellular metabolic regulation, energy expenditure kinetics, and substrate oxidation dynamics.

Key Research Properties:

• Triple-Receptor Activation: Evaluated for simultaneous affinity at GIP, GLP-1, and Glucagon receptor sites for multi-pathway signaling.
• Energy Expenditure Modeling: Investigated in cellular assays for glucagon-mediated lipid oxidation and energetic output.
• Glucose Homeostasis Analysis: Evaluated in metabolic models studying insulin secretion dynamics and glycemic control mechanisms.
• High Purity Standard: Independently 3rd-party laboratory tested to ensure sequence precision, chemical integrity, and maximum purity.

Ideal For:

• In-vitro triple-receptor agonist research
• Cellular energy expenditure and lipolysis assays
• Glucose regulation and insulin pathway modeling
• Multi-target endocrine system investigations

Standard empirical research assays utilize benchmark working concentrations ranging from 2 mg to 12 mg per test subject/model interval. Specific working parameters depend on experimental protocol objectives.

Add 1mL of sterile bacteriostatic water to achieve a working concentration of 10mg/mL (where 0.1mL / 10 units on a standard syringe equals 1mg of Retatrutide).

Storage: Store unmixed lyophilized vials in a cool, dark environment away from direct light. Once reconstituted, store under refrigeration between 2°C – 8°C (36°F – 46°F) and use within 30 days.

Disclaimer: This product is sold strictly as a laboratory research chemical and is not intended for human or animal consumption, medical, diagnostic, or therapeutic use.